1. Home
  2. VIR vs REAL Comparison

VIR vs REAL Comparison

Compare VIR & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$10.59

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$10.86

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
REAL
Founded
2016
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
VIR
REAL
Price
$10.59
$10.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
9
Target Price
★ $21.00
$18.00
AVG Volume (30 Days)
1.8M
★ 2.8M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
17.49
★ 43.55
EPS
N/A
★ N/A
Revenue
$68,556,000.00
★ $692,845,000.00
Revenue This Year
$257.66
$14.82
Revenue Next Year
N/A
$11.05
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 15.38
52 Week Low
$4.82
$8.05
52 Week High
$12.00
$17.39

Technical Indicators

Market Signals
Indicator
VIR
REAL
Relative Strength Index (RSI) 47.63 61.88
Support Level $10.00 $10.51
Resistance Level $11.83 $11.98
Average True Range (ATR) 0.62 0.53
MACD -0.08 0.18
Stochastic Oscillator 30.62 86.15

Price Performance

Historical Comparison
VIR
REAL

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About REAL The RealReal Inc.

The RealReal Inc is an online marketplace for authenticated, resale luxury goods, providing an end-to-end service that unlocks supply and creates a trusted, curated marketplace for buyers globally. Since its inception, the company has cultivated a loyal and engaged consignor and buyer base through continuous investment in its technology platform, logistics infrastructure, brand and people. It offers a wide selection of authenticated, mainly pre-owned luxury goods bearing the brands of thousands of luxury and premium designers, including Cartier, Chanel, Christian Dior, Gucci, Hermes, Louis Vuitton and Rolex. The company offers products across women's fashion, men's fashion, jewelry, and watches, promoting the recirculation of luxury goods and contributing to a more sustainable world.

Share on Social Networks: